NeueHealth Company Insiders
NEUE Stock | 5.14 0.48 10.30% |
NeueHealth's insiders are aggressively selling. The analysis of insiders' sentiment of trading NeueHealth stock suggests that all insiders are panicking at this time. NeueHealth employs about 1.3 K people. The company is managed by 10 executives with a total tenure of roughly 2922 years, averaging almost 292.0 years of service per executive, having 125.2 employees per reported executive.
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-03-14 | George Lawrence Mikan III | Disposed 12440 @ 6.13 | View | ||
2025-03-13 | Jay Matushak | Disposed 4448 @ 6.74 | View | ||
2025-03-12 | Tomas Orozco | Disposed 1300 @ 6.93 | View | ||
2025-03-11 | Jay Matushak | Disposed 814 @ 6.85 | View | ||
2025-03-10 | George Lawrence Mikan III | Disposed 1604 @ 7.06 | View | ||
2025-03-07 | George Lawrence Mikan III | Disposed 26660 @ 7.19 | View | ||
2025-01-06 | Jay Matushak | Disposed 4970 @ 7.33 | View |
Monitoring NeueHealth's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
NeueHealth |
NeueHealth Management Team Effectiveness
The company has return on total asset (ROA) of (0.051) % which means that it has lost $0.051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8326) %, meaning that it created substantial loss on money invested by shareholders. NeueHealth's management efficiency ratios could be used to measure how well NeueHealth manages its routine affairs as well as how well it operates its assets and liabilities. At present, NeueHealth's Return On Equity is projected to increase slightly based on the last few years of reporting. At present, NeueHealth's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 155.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 31.5 M.As of March 19, 2025, Common Stock Shares Outstanding is expected to decline to about 8 M
NeueHealth Workforce Comparison
NeueHealth is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 9,697. NeueHealth retains roughly 1,252 in number of employees claiming about 13% of equities under Health Care industry.
NeueHealth Profit Margins
The company has Profit Margin (PM) of (0.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.1 | 0.13 |
|
|
NeueHealth Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NeueHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on NeueHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, NeueHealth insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NeueHealth Notable Stakeholders
A NeueHealth stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as NeueHealth often face trade-offs trying to please all of them. NeueHealth's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting NeueHealth's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
George III | CEO Chairman | Profile | |
Robert Sheehy | CoFounder Chairman | Profile | |
Megan North | President NeueSolutions | Profile | |
Joaquin MD | President Care | Profile | |
Jeff Craig | General Secretary | Profile | |
Jeffrey Scherman | Chief Officer | Profile | |
Jay Matushak | Chief Officer | Profile | |
Tomas Orozco | Executive Care | Profile | |
Stacy Conti | Chief Officer | Profile | |
Jeff JD | General Secretary | Profile |
About NeueHealth Management Performance
The success or failure of an entity such as NeueHealth often depends on how effective the management is. NeueHealth management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NeueHealth management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NeueHealth management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.17) | (1.11) | |
Return On Capital Employed | 3.13 | 3.29 | |
Return On Assets | (1.08) | (1.03) | |
Return On Equity | 3.02 | 3.17 |
Please note, the presentation of NeueHealth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NeueHealth's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NeueHealth's management manipulating its earnings.
NeueHealth Workforce Analysis
Traditionally, organizations such as NeueHealth use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare NeueHealth within its industry.NeueHealth Manpower Efficiency
Return on NeueHealth Manpower
Revenue Per Employee | 927.2K | |
Revenue Per Executive | 116.1M | |
Net Loss Per Employee | 919.7K | |
Net Loss Per Executive | 115.1M |
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |